Processa Pharmaceuticals, Inc. Common (PCSA)
Processa Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing pharmaceutical products for serious and unmet medical conditions. The company emphasizes innovative drug development, often targeting niche markets with unmet needs, leveraging its expertise in formulation and clinical development processes.
Company News
Processa Pharmaceuticals announced the acceptance of three abstracts for the 2025 ASCO Annual Meeting, highlighting its pipeline of Next Generation Cancer (NGC) drug candidates, including PCS6422 (NGC-Cap) and PCS11T (NGC-Iri).
Here's how to spot penny stocks with potential uptrends The post Spotting Penny Stocks Uptrends, 3 Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Abeona Therapeutics The Trade: Abeona Therapeutics Inc. (NASDAQ: ABEO) Director, Chief Executive Officer Vishwas Seshadri acquired a total of 20,000 shares ...
Heatwurx Inc. (PCSA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.